The Lupin Human Welfare and Research Foundation was established by our Founder, Dr. Desh Bandu Gupta, in 1988, dedicated to promoting good health and fostering economic growth through sustainable livelihood in India’s most marginalized regions. Over the last three decades, LHWRF’s efforts have centered around agriculture, animal husbandry, women’s empowerment, and rural industries. Through structured long term programs and strategic partnerships with governmental and nongovernmental entities, international development agencies, and philanthropic organizations, we have reached out to over 1.57 Mn beneficiaries in more than 4,771 villages across eight states in India. Various initiatives, such as upgrading local infrastructure and enhancing access to healthcare and education, have led to a positive impact on the lives and livelihoods of these communities. This demonstrates our unwavering dedication to social upliftment and economic development through collaborations with community-based organizations as well as local institutions.
Understanding the aspirations and perspectives of our communities is paramount in crafting effective programs. By prioritizing their voices and needs, we ensure that our initiatives are not just responsive but also tailored to address the specific challenges and opportunities within our communities. This approach underscores the importance of a nuanced, need-based strategy that places the empowerment and fulfillment of individuals at its forefront, driving sustainable change from within the community.
Lives Programs
| Desh Bandhu Jan Utkarsh Pariyojna | |
|---|---|
|
|
|
|
|
Key Impact
|
|
| Pioneering Initiatives for the Advancement of Cotton Agriculturists | |
|---|---|
|
|
|
Elevating Agriculture Through Digital Innovation and Sustainability Practices
|
|
|
Key Impacts of the Project
|
|
Robust governance mechanisms drive our social initiatives and optimize social capital. The Board of Trustees, supported by the CSR Committee and the LHWRF, oversees the implementation of our programs. The Board ensures effective CSR policy implementation and fund allocation, while the CSR Committee moderates plans, monitors projects, and evaluates impact. LHWRF directly manages project execution, ensuring ethical practices and compliance. Collaborations with government agencies, local partners, institutions, self help groups, NGOs, and experts enable us to leverage resources and expertise for successful implementation.
As responsible corporate citizens, we are cognizant of the importance of regular evaluations to ensure that our programs make a meaningful impact. Such assessments also serve to reorient our programs to meet the needs of the community. In adherence to this, during FY24, we conducted an independent third-party impact assessment of district development programs in Dhule, Sindhudurg, Pune, Bharatpur, and Alwar. Conducted by CSR Box, this assessment evaluated key subprograms implemented by LHWRF, including agriculture, animal husbandry, skill and enterprise development, women empowerment, water resource development, tree plantation, upgradation of healthcare services, digitalization of schools and infrastructure development in rural areas. The study provided a comprehensive analysis of the social value of these programs, guiding our investment assessments.
| Areas | Intervention | Social Return on Investment | ||||
|---|---|---|---|---|---|---|
| Sindhudurg | Bharatpur | Alwar | Pune | Dhule | ||
| Agriculture | Crop Yield Enhancement | 44.61 | 3.06 | 12.56 | 16.90 | 5.69 |
| Promotion of Horticulture | 11.60 | 12.20 | ||||
| Bee Keeping | 7.10 | |||||
| Land Levelling | 7.40 | |||||
| Animal Husbandry | Dairy | 5.58 | 5.91 | 33.21 | 5.91 | |
| Goat Rearing | 2.93 | 0.43 | 4.76 | |||
| Poultry | 6.00 | 1.45 | 2.24 | |||
| Rural Industrialization | Skill and Enterprise Development | 43.98 | 4.66 | 22.30 | 6.95 | 5.04 |
Our Employee Volunteering initiatives have significantly impacted the communities we serve, with our team dedicating 19,188 hours of service to various meaningful activities. These efforts reflect our strong commitment to environmental, social, and governance (ESG) principles, reinforcing our role as responsible corporate citizens.
At the heart of our business philosophy lies our commitment to fostering profound relationships built on transparency, trust, and open communication grounded in shared values. We nurture respectful and mutually beneficial connections with stakeholders, underpinning our business conduct. Our diverse network spans patients, healthcare professionals, channel partners, government entities, suppliers, shareholders, industry bodies, media, regulatory authorities, employees, and society.
Throughout its history, Lupin has significantly impacted patients’ lives, particularly in the fight against TB, where we are the largest supplier of primary anti-TB medications. Our commitment to ensuring access to safe, effective, and quality medicines and health products is fundamental to preserving and improving the health of millions. Leveraging our global presence, we have pioneered health solutions for both regulated and non regulated markets.
Recognizing the importance of comprehensive patient centric care, we have expanded our scope to include diagnostics and healthcare solutions, initially focusing on cardiovascular and diabetes care. In response to evolving priorities and the demands of the digital era, Lupin has initiated a robust digital transformation program. This initiative aims to streamline patient interactions and internal processes, aligning with our commitment to improving healthcare accessibility and connectivity. By leveraging digital technologies, we facilitate timely interventions and enhance treatment efficiency, ultimately leading to better patient outcomes. Concurrently, we focus on optimizing processes across various functions to drive quality and efficiency improvements.
Through our digital platform connecting cardiovascular and diabetes patients with healthcare professionals and practitioners, we have significantly enhanced accessibility in healthcare delivery. This seamless integration facilitates quicker interventions, placing patient well-being at the forefront of our endeavors.
We are committed to ensuring that everyone, regardless of their geographical location or socio-economic status, benefits from our pharmaceutical innovations. In our efforts to combat TB, particularly in regions with limited resources, we operate multiple state-of-the-art facilities dedicated to anti-TB products. As one of the largest manufacturers of Rifampicin, Pyrazinamide, and Ethambutol Active Pharmaceutical Ingredients, we have expanded our production capabilities in Aurangabad, increasing our output by 40% from our specialized anti- TB formulation blocks. Our generics offer significant cost savings worldwide. In the U.S., Lupin ranks #3 by prescriptions, holding a 4.7% share of total prescriptions, contributing to USD 373 Bn in savings. Similarly, in South Africa, Lupin has helped reduce healthcare expenditures by 35%, and in the U.K., our products have generated 30- 50% savings for the government.
We are also launching 2-3 programs in India and building capacities in healthcare systems where we operate. Our commitment to not patenting or enforcing patents on intellectual property related to products for diseases covered by ATMI 2021 in least developed and low income countries ensures affordable and accessible medications for those in need.
Through Lupin Access Business, we have successfully registered our products in low and middle income countries, surpassing 115 registrations to date. In FY24, we secured 80+ registrations across various nations, marking significant milestones in expanding the global reach of Lupin’s antiretroviral and tuberculosis treatments, fostering greater accessibility to life-saving medications worldwide.
At the core of our mission is the commitment to advancing healthcare and fulfilling patient needs. This necessitates a collaborative relationship with health care organizations and health care professionals to leverage scientific expertise effectively. We offer compensation to HCPs for their invaluable time and expertise and provide financial assistance to HCOs for patient care, NHS initiatives, and R&D endeavors.
We strictly adhere to the guidelines set forth by the Association of the British Pharmaceutical Industry, maintaining transparency by disclosing all payments and benefits. Our flagship programs are meticulously designed to enhance understanding and knowledge with regard to the optimal use of our products. Through comprehensive educational initiatives for both healthcare providers and patients, we ensure that they are well informed about the benefits and appropriate usage of our treatments.
At Lupin, our focus is on building strong relationships with our diverse customer base, which includes healthcare providers, government agencies, pharmacies, and hospitals. Our commitment is to deliver exceptional service and ensure customer satisfaction in every interaction. We believe that outstanding customer service is key to consistently exceeding expectations.
Our proactive involvement in notable industry events allows us to directly engage with our customers, providing a platform for sharing insights, discussing industry trends, and fostering collaborative opportunities.
Our senior leadership’s accessibility underscores our customer-centric commitment. Executives, including the CEO and other senior leaders, actively engage with customers to align strategic objectives. Regular updates on sales activities, product launches, and opportunities for collaborative growth during business reviews demonstrate our dedication to transparency and mutual success.
We prioritize delivering best-in-class service levels through trustworthy and long-term partnerships within our global supplier network. This dedication allows us to consistently provide high quality healthcare solutions to our customers.
Our extensive global network of suppliers and business partners, including manufacturers, service providers, wholesalers, and distributors, ensures efficient delivery of our medicines to patients. We proactively explore opportunities to derisk our supply chain by evaluating alternate suppliers for critical or non substitutable raw material. As part of our Supplier Code of Conduct, we expect suppliers to adhere to Lupin’s ESG standards. We enforce stringent contractual agreements that mandate compliance with our standards for quality, ethics, environmental sustainability, and human rights across all third-party engagements. We promote a culture of continuous improvement and collaboration with our partners, emphasizing the development of quality products to enhance consumer safety. We also ensure the quality of raw materials through periodic supplier audits.
At Lupin, we recognize the importance of long-term commercial partnerships with our suppliers. These relationships are sustained through a robust commitment to social, environmental, and safety standards, ensuring our business value remains uncompromised. Our Supplier ESG Program plays a pivotal role in this commitment. Through our Supplier ESG Program, we meticulously track the environmental, social, and governance impact within our supply chain. This monitoring is particularly focused on critical direct material suppliers, ensuring they meet our stringent ESG criteria. To align our suppliers with Lupin’s organizational goals, we have conducted multiple webinars, educating them on the importance of ESG compliance. These educational efforts are crucial for fostering a shared understanding of our ESG expectations and enhancing supplier performance. In FY24, we undertook a comprehensive ESG evaluation of 309 suppliers who are either strategic or critical to our operations. The assessments enabled us to identify those suppliers needing intervention to meet Lupin’s ESG requirements. For those who have certain development areas, we have designed and implemented Corrective and Preventive Action plans. These tailored plans address specific deficiencies, requiring suppliers to submit detailed improvement strategies. We track these CAPA plans periodically to ensure that improvements are being made and that sustainability standards are consistently met.
Environmental Sustainability
Community Health
Education and Social Development
Cultural and Social Cohesion
Rural Infrastructure
Assurance Statement